Hims & Hers Shares Rise After Announcing Acquisition Valued at Up to $1.15 Billion

Hims & Hers Health (HIMS) officially announced on Thursday a definitive agreement to acquire Eucalyptus, a prominent international player in the digital health sector. The acquisition deal is valued at up to $1.15 billion, suggesting the inclusion of contingent or performance-based payments. Following the announcement, HIMS shares rose 0.5% to trade at $15.91 on the New York Stock Exchange (NYSE). This strategic move is designed to accelerate the company’s mission of providing personalized healthcare on a global scale, specifically targeting the Australian market. The expansion comes as Hims & Hers continues to see robust growth within its core United States operations. By integrating Eucalyptus, the company aims to scale its personalized care model and solidify its position as a leading global consumer health platform, ensuring long-term revenue diversification.